MTTlab & Giotto Biotech announce collaboration to bring preclinical drug discovery studies and NMR metabolomics together.

The new collaboration allows us to offer state of the art NMR metabolomic analysis in all in vivo studies for the preclinical evaluation of investigational compounds.

The combination of top level technology and expertise from both fields amassed by both MTTlab and Giotto Biotech has been streamlined into an integrated workflow process which becomes more than the sum of its parts, providing significant advantages to our clients. The resulting turn-key service was designed so that the client need only send the drug candidate or lead compound and provide additional information. A toxicity and/or efficacy study on an appropriate animal model will then be performed with the relevant end-point readouts (including biochemical, histopathological and metabolomics analysis). At the end of each study a final report is prepared in a standardized format.